© Olivier Papegnies

Drugs and therapeutic advances: Guaranteeing access

Our programs in France
Faced with significant price increases for new drugs, in North and South alike, particularly drugs for cancer, hepatitis C and rare diseases, civil society in France is taking action to defend access to best-quality care for all, and to safeguard the public healthcare system. Several organisations representing patients, healthcare users, healthcare professionals and students have joined together to publish a White Paper (in French) entitled: “Drugs and therapeutic advance: guaranteeing access, bringing prices under control”.

Based on our shared position, our 8 organisations contributed 12 texts, collected together in this White Paper, which aims to speak on behalf of civil society in the public debate.

Global loader